Pharma giant AstraZeneca has put its U.S. HQ up for sale. Fear not, though, according to a News Journal report: the drugmaker is looking to sell the Fairfax campus and then lease space from the new owner.
“In order to fully explore this [redevelopment] possibility, AstraZeneca will be soliciting bids from real estate developers in the coming months and that requires us putting the site on the market for sale,” AstraZeneca spokeswoman Abigail Bozrath told the paper.
Read the full story
The company expressed interest in relocating or redesigning its U.S. home base in a statement back in May.
Join our growing Slack community
Join 5,000 tech professionals and entrepreneurs in our community Slack today!
Donate to the Journalism Fund
Your support powers our independent journalism. Unlike most business-media outlets, we don’t have a paywall. Instead, we count on your personal and organizational contributions.
